Skip to content

Efficacy evaluation of probiotic chewable tablets in adjuvant periodontal basic therapy

A randomized, double-blind clinical trial of Lactobacillus fermentum CCFM1139 and Lactobacillus rhamnosus CCFM1138 in relieving periodontitis (phase II periodontitis)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065070
Enrollment
Unknown
Registered
2022-10-27
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Interventions

1:Live Lactobacillus fermentum CCFM1139
2:Inactivated Lactobacillus fermentans CCFM1139
3:Live Lactobacillus rhamnosus CCFM1138
5:Baseline examination and sample collection

Sponsors

Wuxi Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-65 years old; 2. Patients with periodontitis: Stage II periodontitis (European Union of Periodontology and American Society of Periodontology new classification), PD<=5 mm, maximum interdental attachment loss: 3 mm<=CAL<=4 mm, X-ray alveolar bone resorption extends to 1/3 of the root crown, and no tooth loss due to periodontitis. The healthy group: 24 natural teeth (excluding the third molar)at least; PD <= 3 mm, BOP positive sites less than 10%; No induced oral factors caused local irritation and plaque retention; There were no imaging signs of clinical attachment loss or alveolar bone destruction, and no history of periodontitis; 3. The lifestyle remained unchanged and healthy during the study period.

Exclusion criteria

Exclusion criteria: 1. Have periodontal treatment or antibacterial treatment related to the cause in the past 6 months; 2. Have systemic diseases that may affect the progression or treatment response of periodontitis (such as respiratory diseases, type 1 and type 2 diabetes); 3. Smokers; 4. Have routine dental surgery that requires prophylactic antibiotic treatment; 5. Long term using of anti-inflammatory drugs; 6. Use probiotics 2 months before the study; 7. Pregnant or lactating women; 8. Fail to follow the oral hygiene instructions provided or / and maintain regular appointments.

Design outcomes

Primary

MeasureTime frame
clinical attachment loss;probing depth;plaque index;bleeding index;bleeding on probing;

Countries

China

Contacts

Public ContactFeng Chenchen/Cui Shumao
cuishumao@jiangnan.edu.cn18352520928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026